Alignment Healthcare, Inc. (NASDAQ:ALHC) President Sells $479,700.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of the stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $15.99, for a total value of $479,700.00. Following the sale, the president now directly owns 2,417,700 shares of the company’s stock, valued at approximately $38,659,023. The trade was a 1.23 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Dawn Christine Maroney also recently made the following trade(s):

• On Wednesday, March 19th, Dawn Christine Maroney sold 16,535 shares of Alignment Healthcare stock. The shares were sold at an average price of $16.40, for a total transaction of $271,174.00.
• On Wednesday, March 12th, Dawn Christine Maroney sold 27,243 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.43, for a total transaction of $420,359.49.
• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.53, for a total transaction of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.72, for a total value of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.61, for a total value of $408,300.00.

Alignment Healthcare Trading Up 2.7 %

Alignment Healthcare stock opened at $17.19 on Thursday. The stock has a 50-day simple moving average of $14.68 and a 200 day simple moving average of $12.59. The stock has a market capitalization of $3.30 billion, a P/E ratio of -22.32 and a beta of 1.49. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. Alignment Healthcare, Inc. has a 52 week low of $4.46 and a 52 week high of $17.38.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in ALHC. R Squared Ltd bought a new stake in Alignment Healthcare in the 4th quarter valued at $55,000. RiverPark Advisors LLC bought a new stake in shares of Alignment Healthcare during the 4th quarter worth about $106,000. Tower Research Capital LLC TRC grew its stake in Alignment Healthcare by 146.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock valued at $119,000 after buying an additional 6,286 shares during the last quarter. Ballentine Partners LLC bought a new position in Alignment Healthcare in the 4th quarter valued at about $121,000. Finally, Aigen Investment Management LP acquired a new stake in Alignment Healthcare during the fourth quarter worth approximately $129,000. 86.19% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have commented on ALHC. Barclays boosted their target price on Alignment Healthcare from $8.00 to $9.00 and gave the company an “underweight” rating in a research note on Friday, February 28th. JPMorgan Chase & Co. boosted their price objective on shares of Alignment Healthcare from $14.00 to $17.00 and gave the stock a “neutral” rating in a research report on Thursday, March 6th. Piper Sandler raised their target price on shares of Alignment Healthcare from $14.00 to $21.00 and gave the company an “overweight” rating in a research report on Tuesday, March 4th. William Blair reissued an “outperform” rating on shares of Alignment Healthcare in a research report on Friday, February 28th. Finally, Stifel Nicolaus raised their price objective on Alignment Healthcare from $16.00 to $18.00 and gave the company a “buy” rating in a report on Friday, February 28th. One analyst has rated the stock with a sell rating, three have given a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $14.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.